Clough Capital Partners L P Regeneron Pharmaceuticals, Inc. Transaction History

Clough Capital Partners L P

  • $924 Million
  • Q3 2024

A detailed history of Clough Capital Partners L P transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Clough Capital Partners L P holds 715 shares of REGN stock, worth $510,846. This represents 0.08% of its overall portfolio holdings.

Number of Shares
715
Previous 715 -0.0%
Holding current value
$510,846
Previous $751,000 -0.0%
% of portfolio
0.08%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $108,525 - $123,438
140 Added 24.35%
715 $627,000
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $5.01 Million - $6.1 Million
-7,230 Reduced 92.63%
575 $473,000
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $5.46 Million - $6.48 Million
7,805 New
7,805 $5.61 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $15.5 Million - $18.2 Million
-26,040 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $3.77 Million - $4.66 Million
-6,945 Reduced 21.06%
26,040 $16.4 Million
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $12.9 Million - $15.3 Million
-22,535 Reduced 40.59%
32,985 $20 Million
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $26.2 Million - $31 Million
55,520 New
55,520 $31 Million
Q1 2021

May 17, 2021
SELL
$446.73 - $548.2 $3.75 Million - $4.6 Million
-8,384 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $7.13 Million - $9.06 Million
-14,908 Reduced 64.0%
8,384 $4.05 Million
Q3 2020

Nov 17, 2020
SELL
$544.75 - $658.21 $3.17 Million - $3.83 Million
-5,823 Reduced 20.0%
23,292 $13 Million
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $4.01 Million - $5.23 Million
-8,120 Reduced 21.81%
29,115 $18.2 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $3.45 Million - $5.07 Million
10,255 Added 38.01%
37,235 $18.2 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $7.4 Million - $10.2 Million
26,980 New
26,980 $10.1 Million

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email